PubMed (GeneRIF) for id: 85004

Year	Number of Results
2008	1
2009	3
2010	2
2011	2
2014	1
2017	2
2018	1
2019	1
2020	1
2024	0

1

NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.

Jin S, Li X, Dai Y, Li C, Wang D. Jin S, et al. Cell Oncol (Dordr). 2020 Dec;43(6):1035-1048. doi: 10.1007/s13402-020-00533-5. Epub 2020 Sep 25. Cell Oncol (Dordr). 2020. PMID: 32986146

2

ERK5‑regulated RERG expression promotes cancer progression in prostatic carcinoma.

Xiong Y, Huang H, Chen S, Dai H, Zhang L. Xiong Y, et al. Oncol Rep. 2019 Feb;41(2):1160-1168. doi: 10.3892/or.2018.6852. Epub 2018 Nov 5. Oncol Rep. 2019. PMID: 30431143

3

Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.

Zhao W, Mo Y, Wang S, Midorikawa K, Ma N, Hiraku Y, Oikawa S, Huang G, Zhang Z, Murata M, Takeuchi K. Zhao W, et al. BMC Cancer. 2017 Jul 17;17(1):489. doi: 10.1186/s12885-017-3482-3. BMC Cancer. 2017. PMID: 28716111 Free PMC article.

4

MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.

Ho JY, Hsu RJ, Liu JM, Chen SC, Liao GS, Gao HW, Yu CP. Ho JY, et al. Oncotarget. 2017 Apr 4;8(14):22443-22459. doi: 10.18632/oncotarget.12338. Oncotarget. 2017. PMID: 27705918 Free PMC article.

5

ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis.

Monsivais D, Dyson MT, Yin P, Coon JS, Navarro A, Feng G, Malpani SS, Ono M, Ercan CM, Wei JJ, Pavone ME, Su E, Bulun SE. Monsivais D, et al. Mol Endocrinol. 2014 Aug;28(8):1304-15. doi: 10.1210/me.2013-1421. Epub 2014 Jul 3. Mol Endocrinol. 2014. PMID: 24992181 Free PMC article.

6

Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Chile T, Corrêa-Giannella ML, Fortes MA, Bronstein MD, Cunha-Neto MB, Giannella-Neto D, Giorgi RR. Chile T, et al. J Endocrinol Invest. 2011 Sep;34(8):e214-8. doi: 10.3275/7481. Epub 2011 Jan 26. J Endocrinol Invest. 2011. PMID: 21270509

7

RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.

Habashy HO, Powe DG, Glaab E, Ball G, Spiteri I, Krasnogor N, Garibaldi JM, Rakha EA, Green AR, Caldas C, Ellis IO. Habashy HO, et al. Breast Cancer Res Treat. 2011 Jul;128(2):315-26. doi: 10.1007/s10549-010-1073-y. Epub 2010 Aug 10. Breast Cancer Res Treat. 2011. PMID: 20697807

8

Genetic susceptibility to distinct bladder cancer subphenotypes.

Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, Rothman N, Vellalta G, Calle ML, Marenne G, Tardón A, Carrato A, García-Closas R, Serra C, Silverman DT, Chanock S, Real FX, Malats N; EPICURO/Spanish Bladder Cancer Study investigators. Guey LT, et al. Eur Urol. 2010 Feb;57(2):283-92. doi: 10.1016/j.eururo.2009.08.001. Epub 2009 Aug 12. Eur Urol. 2010. PMID: 19692168 Free PMC article.

9

PTEN identified as important risk factor of chronic obstructive pulmonary disease.

Hosgood HD 3rd, Menashe I, He X, Chanock S, Lan Q. Hosgood HD 3rd, et al. Respir Med. 2009 Dec;103(12):1866-70. doi: 10.1016/j.rmed.2009.06.016. Epub 2009 Jul 21. Respir Med. 2009. PMID: 19625176 Free PMC article.

10

Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.

Shen M, Vermeulen R, Rajaraman P, Menashe I, He X, Chapman RS, Yeager M, Thomas G, Burdett L, Hutchinson A, Yuenger J, Chanock S, Lan Q. Shen M, et al. Environ Mol Mutagen. 2009 May;50(4):285-90. doi: 10.1002/em.20452. Environ Mol Mutagen. 2009. PMID: 19170196 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year